✦ LIBER ✦

Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure

✍ Scribed by D.M. McNamara; R. Holubkov; L. Postava

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenetic interactions between bet

✍ D.M McNamara; R Holubkov; K Janosko 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 52 KB

The Role of Angiotensin-Converting Enzym

✍ Mara Pilati; Mariantonietta Cicoira; Luisa Zanolla; Ilaria Nicoletti; Simone Mur 📂 Article 📅 2004 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 287 KB

Angiotensin-converting enzyme inhibitor

✍ Ya-Ting Chen; Yun Wang; Martha J. Radford; Harlan M. Krumholz 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 91 KB

The use of angiotensin-converting enzyme

✍ Jean L. Rouleau; Carl Juneau; Jacques de Champlain 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 670 KB

Effect of combined aspirin and angiotens

✍ Kishore J. Harjai; Eduardo Nunez; Tansel Turgut; Jeff Newman 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Angiotensin-converting enzyme inhibitor

✍ Faiez Zannad 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 649 KB